Development and validation of a prediction model for people with mild chronic kidney disease in Japanese individuals

Takahiro Miki1, Toshiya Sakoda2, Kojiro Yamamoto2

  • 1PREVENT Inc, Nagoya, Japan. miki.takahiro@prevent.co.jp.

BMC Nephrology
|October 9, 2024
PubMed

Insights

A new prediction model helps identify Japanese individuals with mild chronic kidney disease (CKD) at high risk for heart disease, stroke, or kidney events, enabling earlier intervention.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) presents significant health risks, often asymptomatic in early stages, and is linked to increased cardiovascular and kidney events.
  • Early detection and proactive management are crucial for mitigating adverse outcomes in CKD patients.

Purpose of the Study:

  • To develop and validate a prediction model for hospitalization due to ischemic heart disease (IHD) or cerebrovascular disease (CVD) and major kidney events.
  • To utilize readily available health check and prescription data for risk stratification in Japanese individuals with mild CKD.

Main Methods:

  • A retrospective cohort study analyzed data from approximately 850,000 individuals (40,351 included) from the PREVENT Inc. database (April 2013-April 2023).
  • Cox proportional hazard regression models were employed to derive and validate risk scores, incorporating traditional risk factors and CKD-specific variables.
  • Model performance was evaluated using the concordance index (c-index) and 5-fold cross-validation.

Main Results:

  • Key predictors for IHD/CVD hospitalization and major kidney events included age, sex, diabetes, hypertension, and lipid levels.
  • Age was a significant risk factor for both cardiovascular and kidney events.
  • The developed risk models showed predictive capabilities with mean c-indexes of 0.75 for IHD/CVD and 0.69 for major kidney events.

Conclusions:

  • The developed prediction model serves as a practical tool for early identification of high-risk Japanese individuals with mild CKD.
  • Timely interventions based on this model can improve patient outcomes and potentially reduce healthcare costs.
  • Further clinical validation is recommended to confirm the model's utility in diverse populations.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
2
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
2
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
2
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
2
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
59